| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000041011 |
| Receipt No. | R000046835 |
| Scientific Title | Efficacy of preoperative nutritional guidance for living kidney transplant marginal donors |
| Date of disclosure of the study information | 2020/07/13 |
| Last modified on | 2021/01/05 (Ver. 4) |
| Basic information | ||
| Public title | Efficacy of preoperative nutritional guidance for living kidney transplant marginal donors | |
| Acronym | Efficacy of preoperative nutritional guidance for living kidney transplant marginal donors | |
| Scientific Title | Efficacy of preoperative nutritional guidance for living kidney transplant marginal donors | |
| Scientific Title:Acronym | Efficacy of preoperative nutritional guidance for living kidney transplant marginal donors | |
| Region |
|
|
| Condition | |||
| Condition | Bio-Renal Transplantation Marginaldner
|
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The purpose of the study is to evaluate the effectiveness of nutritional guidance 1 months prior to surgery in patients who meet the Marginaldner criteria and who, among other things, are obese (BMI less than 32 kg/m2) or hypertensive (blood pressure strictly controlled to less than 130/80 mmHg with the use of antihypertensive medication and urinary albumin excretion less than 30 mg/gCr and no organ damage such as myocardial hypertrophy or renal dysfunction due to hypertension). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Decline in weight and BMI at 3 months post-operatively, fluctuations in blood biochemistry data, blood pressure trends, and antihypertensive medication doses.
transition |
| Key secondary outcomes | Six months post-operatively, weight and BMI decline, blood biochemistry data variation, blood pressure trends, and antihypertensive medication intake. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Nutritional guidance and assessments are provided 1 months prior to surgery after the decision to transplant the kidney, and 3 and 6 months after kidney transplantation. to provide nutritional guidance and evaluation. Preoperative nutritional guidance includes guidance on blood pressure and weight control, salt reduction and evaluation of nutritional status. Postoperatively, the changes in blood pressure and weight control and the change in the amount of antihypertensive medication are checked and the nutritional status is evaluated. Guidance on blood pressure, weight control, and salt reduction is provided as needed. | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Patients who are 80 years of age or younger at the time of obtaining consent
(2) Patients who meet the Marginal Donor Criteria of the Japanese Society for Transplantation's Living Donor Guidelines for Kidney Transplantation (3) Patients diagnosed as obese (BMI 32 kg/m2 or less) Hypertension [strictly controlled to 130/80 mmHg with antihypertensive medication and urinary albumin The amount of excretion. Less than 30 mg/gCr and organ damage due to hypertension (myocardial hypertrophy, fundus changes, aortic advanced stone Patients diagnosed with [no ashing, etc.] (5) Outpatients (6) Patients who have given written consent to participate in this study |
|||
| Key exclusion criteria | (1) Patients who are unable to continue to quit smoking
(2) Patients who deviated from the Marginaldner criteria prior to kidney transplantation. (3) Other patients who are deemed by the physician in charge to be inappropriate for the subject |
|||
| Target sample size | 15 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Asahikawa Medical University Hospital | ||||||
| Division name | Nutritional Management Department | ||||||
| Zip code | 078-8510 | ||||||
| Address | Midorigaoka Higashi 2-1-1-1,Asahikawa,Hokkaido | ||||||
| TEL | 0166-69-3085 | ||||||
| kurosaka@asahikawa-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Asahikawa Medical University Hospital | ||||||
| Division name | Nutritional Management Department | ||||||
| Zip code | 078-8510 | ||||||
| Address | Midorigaoka Higashi 2-1-1-1,Asahikawa,Hokkaido | ||||||
| TEL | 0166-69-3085 | ||||||
| Homepage URL | |||||||
| kurosaka@asahikawa-med.ac.jp | |||||||
| Sponsor | |
| Institute | Asahikawa Medical University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | No research funding |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Asahikawa Medical University Hospital |
| Address | Midorigaoka Higashi 2-1-1-1,Asahikawa,Hokkaido |
| Tel | 0166-69-3085 |
| kurosaka@asahikawa-med.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000046835 |